000 01620 a2200517 4500
005 20250517022305.0
264 0 _c20160125
008 201601s 0 0 eng d
022 _a1476-5365
024 7 _a10.1038/bmt.2015.19
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlam, N
245 0 0 _aRisk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD.
_h[electronic resource]
260 _bBone marrow transplantation
_cMay 2015
300 _a734-42 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAcute Disease
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aGraft vs Host Disease
_xgenetics
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aInterferon-gamma
_xgenetics
650 0 4 _aInterleukin-6
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Biological
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aRisk Factors
650 0 4 _aSurvival Rate
650 0 4 _aUnrelated Donors
700 1 _aXu, W
700 1 _aAtenafu, E G
700 1 _aUhm, J
700 1 _aSeftel, M
700 1 _aGupta, V
700 1 _aKuruvilla, J
700 1 _aLipton, J H
700 1 _aMessner, H A
700 1 _aKim, D D H
773 0 _tBone marrow transplantation
_gvol. 50
_gno. 5
_gp. 734-42
856 4 0 _uhttps://doi.org/10.1038/bmt.2015.19
_zAvailable from publisher's website
999 _c24711298
_d24711298